Patient P-02630

Synthetic patientMETA-24 · Day 169 · 65–74 · M · baseline S17Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Deteriorating

GI state

Improving

Inflammatory state

Deteriorating

Nutritional resilience

Favorable

Discontinuation risk

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S17
Day 21 NP-02 recommended — Dietary Support Protocol NP-02
Day 22 Patient accepted — Started NP-02 in the companion
Day 32 GI symptom burden −13% vs expected — Dietary Support Protocol NP-02
Day 38 Tolerance state changed — Unstable → Improving

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

GI instability-9
Toxicity+6
Inflammatory activity+5
Treatment adherence+3

What helped?

Dietary Support Protocol NP-02Day 21
Result: symptom burden −13%

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

91 min

improving · +4.4 vs previous 14 d

Sleep duration

Wearable

6.3 h

stable · +0.2 vs previous 14 d

Energy level

Daily log

6.6/10

stable · -0.0 vs previous 14 d

Steps

Wearable

9,692

improving · +457 vs previous 14 d

GI burden

Companion

11.2/100

improving · -8.2 vs previous 14 d

Adherence

Companion

96.2 %

stable · +2.4 vs previous 14 d

Sleep quality

Wearable

43.5/100

improving · +3.7 vs previous 14 d

Glucose, CGM daily mean

CGM

129 mg/dL

stable · -3.3 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 87 from the failing basin, 8 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -5.4 next day on high-intake days · n 21

Would not help

Keep alcohol low
GI +4.9 next day on high-intake days · n 19

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-5.4supporter · 95%
Alcohol
+4.9detractor · 95%
Ultra-processed food
-1.4no signal · 28%
Histamine load
-1no signal · 17%
Simple carbohydrates
-0.9no signal · 20%
Insoluble fibre
-0.9no signal · 18%
Caffeine
-0.8no signal · 17%
Dietary fat load
-0.3no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
Autonomic recovery ↑20
- WearableShort sleep window

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 3.6 · butyrate capacity 62/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiLow
Bacteroides fragilisNormal
Bifidobacterium longumLow
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 40 ms
Sleep: 6.6 h
Steps: 8,527
Resting HR: 57 bpm

Daily log: GI score 11, nutritional resilience 68, adherence 96.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02337	31%	S18	DT-01	no change	100
P-02249	35%	S09	DT-01	improved	100
P-02189	36%	S17	—	—	96
P-02640	35%	S03	—	—	96
P-02242	33%	S20	—	—	95
P-02013	40%	S14	BR-03	no change	94
P-02104	40%	S15	—	—	94
P-02450	41%	S12	NP-02	improved	92
P-02277	40%	S05	AD-05	improved	92
P-02304	40%	S15	—	—	92
P-02653	31%	S14	—	—	91
P-02689	33%	S13	—	—	91